![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0589.png)
Question 3
•
Pseudoprogression
A. Occurs in Glioblastoma after concomittant RT-
TMZ in 5% of patients
B. It occurs at 5 months after RT
C. Is more frequent in patients sensitive to TMZ
D. Molecular and functional imaging can help
differenciate true progression from
pseudoprogression
E. It has on impact on response to clinical trials
–
Answer C, D, E